OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Proximity extension assay proteomics and renal single cell transcriptomics uncover novel urinary biomarkers for active lupus nephritis
Yaxi Li, Chenling Tang, Kamala Vanarsa, et al.
Journal of Autoimmunity (2024) Vol. 143, pp. 103165-103165
Open Access | Times Cited: 8
Yaxi Li, Chenling Tang, Kamala Vanarsa, et al.
Journal of Autoimmunity (2024) Vol. 143, pp. 103165-103165
Open Access | Times Cited: 8
Showing 8 citing articles:
Mitoxantrone Combined with Engineered TRAIL‐Nanovesicles for Enhanced Cancer Immunotherapy Via Converting Apoptosis into Pyroptosis
Yi Wang, Boning Niu, Yinmei Tian, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 28
Closed Access | Times Cited: 5
Yi Wang, Boning Niu, Yinmei Tian, et al.
Advanced Healthcare Materials (2024) Vol. 13, Iss. 28
Closed Access | Times Cited: 5
FABP4 inhibition protects renal tubular cells and ameliorates renal inflammation in diabetic kidney disease
Yen‐Wen Wu, Jaw-Wen Chen, Liang-Yu Lin, et al.
Biochemical Pharmacology (2025), pp. 116899-116899
Closed Access
Yen‐Wen Wu, Jaw-Wen Chen, Liang-Yu Lin, et al.
Biochemical Pharmacology (2025), pp. 116899-116899
Closed Access
Downregulation of KLF9 alleviates tubulointerstitial fibrosis by modulating FABP4 ‐mediated lipid accumulation
Lin Zhang, Xuejun Wang, Ting Tian, et al.
IUBMB Life (2025) Vol. 77, Iss. 3
Closed Access
Lin Zhang, Xuejun Wang, Ting Tian, et al.
IUBMB Life (2025) Vol. 77, Iss. 3
Closed Access
Urinary Biomarkers for Lupus Nephritis: A Systems Biology Approach
Mohamed H. Omer, Areez Shafqat, Omar Ahmad, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 8, pp. 2339-2339
Open Access | Times Cited: 3
Mohamed H. Omer, Areez Shafqat, Omar Ahmad, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 8, pp. 2339-2339
Open Access | Times Cited: 3
Urinary biomarkers for active Lupus Nephritis that have survived independent validation across cohorts
Sonja Vodehnal, Chandra Mohan
Kidney International (2024)
Closed Access | Times Cited: 2
Sonja Vodehnal, Chandra Mohan
Kidney International (2024)
Closed Access | Times Cited: 2
Lupus Nephritis: Redefining the treatment goals
An S. De Vriese, Sanjeev Sethi, Fernando C. Fervenza
Kidney International (2024)
Open Access | Times Cited: 2
An S. De Vriese, Sanjeev Sethi, Fernando C. Fervenza
Kidney International (2024)
Open Access | Times Cited: 2
Lectin-type oxidized LDL receptor-1 as a potential therapeutic target for cerebral cavernous malformations treatment
Karthik Ashok, Tyra Martinez, Julie Sesen, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 1
Karthik Ashok, Tyra Martinez, Julie Sesen, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 1
Lipocalin-2 and intestinal diseases
Z Y Zhang, Jian Peng, Weiwei Ding
World Journal of Gastroenterology (2024) Vol. 30, Iss. 46, pp. 4864-4879
Closed Access
Z Y Zhang, Jian Peng, Weiwei Ding
World Journal of Gastroenterology (2024) Vol. 30, Iss. 46, pp. 4864-4879
Closed Access
